Grey Matters Health Inc. (CSE: GREY) announced on September 23, 2026, the closing of the second and final tranche of its equity and convertible debenture private placement, bringing total gross proceeds to CAD $1,120,000. The second tranche raised CAD $520,000, complementing the CAD $600,000 first tranche that closed on September 9, 2026. The company intends to deploy the capital toward its Alzheimer's Disease program and the opening of a U.S. brain-specific neuroimaging clinic, a development investors in the Canadian healthcare sector may be watching closely.
Key Points
- Grey Matters Health Inc. (CSE: GREY) (Frankfurt: AGW0) (OTC: AGNPF) is a Vancouver-based Canadian healthcare company
- The two-tranche private placement closed for total gross proceeds of CAD $1,120,000 in equity units and convertible debenture units
- Equity Units priced at CAD $0.40 each, with warrants exercisable at CAD $0.60 for 36 months; Convertible Debentures carry 10% annual interest and convert at CAD $0.455 per share
- Investors will be watching how proceeds are deployed toward the company's planned U.S. neuroimaging clinic and Alzheimer's program milestones
Second Tranche Structure and Equity Unit Terms
The Second Tranche raised CAD $520,000, comprising $270,000 from the sale of 675,000 Equity Units at CAD $0.40 each and $250,000 from Debenture Units. Each Equity Unit consists of one Class A common share and one warrant entitling the holder to acquire an additional common share at CAD $0.60 for a period of 36 months from the issuance date. The company confirmed no cash finder's fees or finder's warrants were paid in connection with the Second Tranche, which may be viewed favourably by shareholders mindful of dilution from placement costs.
Convertible Debenture Terms and Repayment Flexibility
Each Debenture Unit consists of a CAD $1,000 principal convertible debenture and 2,198 common share purchase warrants. The Convertible Debentures carry interest at 10% per annum, payable semi-annually, with a maturity of 24 months from the applicable closing date. Holders may convert outstanding principal and interest into common shares at CAD $0.455 per share before maturity. Additionally, the company retains the right to prepay all or part of the principal and accrued interest at any time without penalty. Debenture Warrants are exercisable at CAD $0.55 per share for 36 months from issuance.
Proceeds Earmarked for U.S. Brain Neuroimaging Expansion
Grey Matters states the Offering proceeds will advance its Alzheimer's Disease program toward opening a U.S. brain-specific neuroimaging clinic, with remaining funds allocated to general and administrative expenses and working capital. The company focuses on brain-dedicated PET scanning services through a planned U.S. clinic network targeting early-stage detection of Alzheimer's Disease and other neurodegenerative conditions. All securities issued under the Offering are subject to a statutory hold period of four months plus one day from issuance under applicable Canadian securities legislation.



Please wait processing your request...